06 febrero 2012

Grifols actualioza ensayo de Fase III Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura (ITP) .

Clinical Trial to Evaluate the Efficacy and the Safety of IGIV3I 10% Grifols (Human Intravenous Immunoglobulin) in Patients Diagnosed With Immune Thrombocytopenic Purpura .

Estimated Enrollment: 20
Study Start Date: February 2008
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure) .

...